MKKGY News and Press, Merck KGaA ADR From 03/07/24

2024-03-07 12:02:03 ET Merck KGaA (MKGAF) Q4 2023 Results Conference Call March 7, 2024 08:00 AM ET Company Participants Constantin Fest - Head of Investor Relations Belen Garijo - Chair & CEO Helene von Roeder - CFO Matthias Heinzel - CEO, Life Science S...

2024-01-08 11:54:11 ET More on Novartis Novartis: Post Investor Day, Higher Guidance Priced In Novartis AG (NVS) 10th Annual ESG Investor Event Conference (Transcript) Sandoz Group: Novartis Spinoff With A Double-Digit EBITDA CAGR Through 2028 Alphabet unit i...

2023-12-19 13:13:17 ET Summary TG Therapeutics, Inc. stock has gone up a lot due to a Q3 revenue beat. However, look closely at the Q3 numbers, and you can see Briumvi wasn't responsible for the revenue beat. Briumvi hasn't done as well as it should have. My TG The...

2023-12-10 02:15:00 ET Summary Shanghai Abbisko Therapeutics has sold greater China commercialization rights for pimicotinib to Germany's Merck in a $605 million deal. Xtalpi, a China-US AI drug discovery company, has filed for a Hong Kong IPO after raising $780 million in venture...

2023-12-07 23:57:14 ET Summary MoonLake Therapeutics is a clinical-stage biopharmaceutical company developing nanobody-based therapies for inflammatory diseases. Their lead product candidate, Sonelokimab, has shown best-in-class potential in treating Hidradenitis suppurativa and P...

2023-12-06 10:11:00 ET More on TG Therapeutics TG Therapeutics: Trying To Fill The Gap Back To $20 TG Therapeutics, Inc. (TGTX) Q3 2023 Earnings Call Transcript TG Therapeutics: Q3 Earnings Spike Hard To Explain Given Rival's Numbers TG Therapeutics gains aft...

2023-11-12 20:42:37 ET Summary Evotec SE's appeal is based on its valuation and upside potential in the drug discovery and development sector. The company's financial performance is average, with negative margins and subpar business model specifics for 2022. Despite some issue...

2023-11-09 14:07:10 ET Merck KGaA (MKGAF) Q3 2023 Earnings Conference Call November 09, 2023, 08:00 ET Company Participants Constantin Fest - Head, IR Belen Garijo - Chair & CEO Helene von Roeder - CFO Kai Beckmann - CEO, Electronics Peter Guenter - C...

2023-11-05 02:15:00 ET Summary Jiangsu Hengrui Pharma out-licensed global rights (ex-China) for its next-gen PARP1 inhibitor to Germany’s Merck KGaA. BioLineRx, an Israeli biotech, out-licensed China rights to a stem cell mobilizer for multiple myeloma and stem cell disease...

2023-10-16 12:27:11 ET Summary Sartorius is facing challenging business conditions due to destocking and delayed customer investment. The company's ability to maintain high levels of sustained growth is a concern due to increasing competition and financing costs. We downgrade ...